Can a double dose stop Post-Procedure pancreatitis?
NCT ID NCT07247682
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two doses of a rectal anti-inflammatory drug (indomethacin) to prevent pancreatitis after an ERCP procedure in people at high risk. About 1,036 adults will be randomly assigned to receive either 100 mg or 200 mg right after the procedure. The goal is to see if the higher dose reduces the number and severity of pancreatitis cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST ERCP PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230022, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple ice water flush prevent pancreatitis after a common procedure?
- Common painkiller may prevent pancreatitis after bile duct procedure
- Can a simple pill prevent pancreatitis after ERCP? new study tests two drugs
- When to remove pancreatic stents? new trial aims to find out
- Could a Half-Dose of a common drug prevent a painful complication just as well?